tiprankstipranks
Trending News
More News >
KRM22 Plc (GB:KRM)
LSE:KRM
Advertisement

KRM22 (KRM) AI Stock Analysis

Compare
1 Followers

Top Page

GB:KRM

KRM22

(LSE:KRM)

Rating:58Neutral
Price Target:
44.00p
▼(-3.30% Downside)
KRM22's overall stock score is primarily impacted by its weak financial performance, characterized by ongoing losses and high leverage. However, strong technical indicators and positive corporate events provide some optimism. The valuation remains a concern due to negative earnings and lack of dividends.

KRM22 (KRM) vs. iShares MSCI United Kingdom ETF (EWC)

KRM22 Business Overview & Revenue Model

Company DescriptionKRM22 (KRM) is a technology and data analytics company that primarily serves the financial services sector. The company specializes in providing risk management and compliance solutions, enabling institutions to effectively manage their trading and investment operations. KRM's core products include advanced software platforms that offer real-time analytics, risk assessment tools, and regulatory compliance services, catering to a diverse clientele that includes banks, hedge funds, and asset managers.
How the Company Makes MoneyKRM22 generates revenue through a subscription-based model for its software solutions, where clients pay for access to its risk management platforms and analytics tools. Key revenue streams include recurring subscriptions from institutional clients, one-time setup fees for new customers, and consulting services that provide tailored risk management strategies. Additionally, KRM has formed strategic partnerships with financial institutions and technology providers, enhancing its service offerings and expanding its market reach, which significantly contributes to its earnings.

KRM22 Financial Statement Overview

Summary
KRM22 faces significant financial challenges with ongoing net losses and high leverage, risking financial stability. Despite revenue growth, profitability remains elusive due to high costs. Positive cash flow from operations is a bright spot, yet overall cash management needs improvement. Immediate actions to improve profitability and reduce leverage are essential for long-term viability.
Income Statement
35
Negative
The company has shown a positive revenue growth trajectory with revenue increasing from the previous year. However, it continues to operate at a net loss, with negative net profit and EBIT margins. The gross profit margin is strong, indicating efficiency in managing production costs, but the negative EBITDA and EBIT margins suggest challenges in overall cost management and profitability.
Balance Sheet
25
Negative
The balance sheet shows a concerning debt-to-equity ratio due to negative stockholders' equity, indicating high leverage and financial instability. The equity ratio is negative, highlighting the company's liabilities exceed its assets. This presents a risk of insolvency if not addressed. Total assets have decreased, further stressing financial health.
Cash Flow
45
Neutral
Positive operating cash flow indicates improved cash management, yet the free cash flow remains low due to significant capital expenditures. The free cash flow growth rate shows improvement from the previous year, but the ratio of operating cash flow to net income indicates inefficiencies in converting income to cash, given the consistent net losses.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.77M5.27M4.27M4.13M4.59M
Gross Profit5.60M4.12M3.32M3.45M4.15M
EBITDA350.00K-3.22M-989.00K-1.29M-3.72M
Net Income-1.29M-4.62M-3.10M-3.33M-5.49M
Balance Sheet
Total Assets7.40M7.81M11.15M14.20M12.59M
Cash, Cash Equivalents and Short-Term Investments1.03M886.00K1.90M5.36M1.97M
Total Debt5.06M4.65M3.59M3.66M3.77M
Total Liabilities9.63M8.91M7.97M7.49M7.64M
Stockholders Equity-2.23M-1.10M3.18M6.71M4.95M
Cash Flow
Free Cash Flow268.00K-2.00M-2.97M-802.00K-1.90M
Operating Cash Flow1.42M-879.00K-2.12M-47.00K-942.00K
Investing Cash Flow-1.16M-1.16M-848.00K-755.00K-961.00K
Financing Cash Flow-122.00K1.04M-535.00K4.19M2.84M

KRM22 Technical Analysis

Technical Analysis Sentiment
Positive
Last Price45.50
Price Trends
50DMA
37.65
Positive
100DMA
33.30
Positive
200DMA
30.64
Positive
Market Momentum
MACD
2.48
Negative
RSI
99.32
Negative
STOCH
93.42
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:KRM, the sentiment is Positive. The current price of 45.5 is above the 20-day moving average (MA) of 41.25, above the 50-day MA of 37.65, and above the 200-day MA of 30.64, indicating a bullish trend. The MACD of 2.48 indicates Negative momentum. The RSI at 99.32 is Negative, neither overbought nor oversold. The STOCH value of 93.42 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:KRM.

KRM22 Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
£5.47B8.789.49%5.10%10.05%-13.15%
63
Neutral
£5.74M7.8810.60%109.71%400.62%
58
Neutral
$16.45M
28.54%72.05%
44
Neutral
£4.47M-12.64%4.76%-0.73%-790.70%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:KRM
KRM22
45.50
17.50
62.50%
GB:WCW
Walker Crips
10.50
-8.24
-43.97%
GB:INV
The Investment
63.00
-8.00
-11.27%

KRM22 Corporate Events

Business Operations and StrategyFinancial Disclosures
KRM22 Reports Strong First Half 2025 Performance with Increased ARR
Positive
Aug 7, 2025

KRM22 plc has reported a positive trading update for the first half of 2025, with an increase in Annual Recurring Revenue (ARR) from £6.6m to £7.2m, driven by cross-sales and price increases. Despite some customer churn, the company maintains a strong sales pipeline and expects to meet market expectations by year-end. The cash balance improved to £1.4m, and KRM22 continues to focus on careful cash management while aiming to become a cash-generative and profitable business.

M&A TransactionsBusiness Operations and Strategy
KRM22 Issues New Shares to Satisfy Deferred Acquisition Payment
Neutral
Jul 21, 2025

KRM22 plc has issued 56,075 new ordinary shares to partially satisfy deferred consideration related to its acquisition of Object+. This move, representing 0.2% of the company’s issued share capital, is part of a strategy to conserve cash. The newly issued shares are expected to commence trading on AIM on 24 July 2025. This decision underscores KRM22’s strategic approach to managing its financial obligations while maintaining operational liquidity, potentially impacting shareholder interests and market positioning.

Business Operations and Strategy
KRM22 Director Increases Stake in Company Shares
Positive
Jun 6, 2025

KRM22 plc announced that Sandy Broderick, a Non-Executive Director, purchased 22,974 ordinary shares of the company, increasing his beneficial interest to 34,739 shares, which represents 0.1% of the company’s issued share capital. This transaction underscores confidence in KRM22’s strategic direction and could positively influence stakeholder perception, potentially impacting the company’s market positioning and investor relations.

Executive/Board ChangesBusiness Operations and Strategy
KRM22 Issues Restricted Stock Units to Employees and Directors
Positive
Jun 2, 2025

KRM22 plc announced the issuance of 2,025,147 Restricted Stock Units (RSUs) to its employees, including significant allocations to CEO Dan Carter and CFO Kim Suter. This issuance is part of a long-term incentive plan linked to the company’s FY24 financial performance and represents a strategic move to align employee interests with company growth. The RSUs will vest in five years and are not subject to future performance conditions, indicating a stable incentive structure. This development underscores KRM22’s commitment to fostering internal investment and aligning leadership with shareholder interests, potentially enhancing its market positioning and stakeholder confidence.

Shareholder MeetingsFinancial Disclosures
KRM22 Announces 2024 Annual Report and 2025 AGM Details
Neutral
May 30, 2025

KRM22 plc has announced the posting of its Annual Report & Accounts for the year ended 31 December 2024, along with the notice of its 2025 Annual General Meeting (AGM). The AGM is scheduled to take place on 27 June 2025 in London. This announcement is significant as it reflects the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.

Business Operations and Strategy
KRM22 Chairman Increases Stake, Reflecting Confidence in Risk Management Strategy
Positive
May 21, 2025

KRM22 plc announced that Garry Jones, the Non-Executive Chairman, has purchased 6,279 ordinary shares of the company, increasing his beneficial interest to 282,750 shares, representing 0.8% of the issued share capital. This transaction highlights confidence in the company’s strategic direction and could positively impact stakeholder perception, reinforcing KRM22’s commitment to enhancing value through its risk management solutions in the capital markets sector.

Executive/Board ChangesBusiness Operations and StrategyFinancial Disclosures
KRM22 Reports Strong Financial Growth and Strategic Advancements in 2024
Positive
May 19, 2025

KRM22 plc reported strong financial results for the year ending December 31, 2024, with a 22.2% increase in Annualised Recurring Revenue (ARR) to £6.6 million and a maiden adjusted EBITDA profit of £1.0 million. The company signed 12 new ARR contracts, launched the Risk Manager application, and implemented a cost savings program. Board changes included appointing Dan Carter as CEO and Garry Jones as Non-Executive Chairman. Post year-end, ARR grew to £7.4 million, and the company deferred interest payments on a convertible loan with Trading Technologies International, Inc. KRM22 is well-positioned for growth, with a strong sales pipeline and high client satisfaction, as it expands its market coverage into new asset classes.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025